Q-Line Biotech Ltd. engages in the business of developing, manufacturing, and marketing of a diverse range of reagents. Its products include clinical chemistry, Haematology, POC testing, molecular diagnostics, rapid tests, ELISA, and special diagnostics. It operates through the Manufacturing and Trading segments. The Manufacturing segment include indigenous manufacturing of reagents including Clinical Chemistry, Haematology, Immunodiagnostics, molecular diagnostics and others, which include POC devices and Rapids. The Trading segment is involved in trading to biochemistry regnant, instruments, and consumables. The company was founded by Saurabh Garg, Amita Garg, and Pushplata Garg on November 10, 2010 and is headquartered in New Delhi, India.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Q-Line Biotech Ltd.?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Q-Line Biotech Ltd. market cap is 14.87B.
What is the 52-week high for Q-Line Biotech Ltd.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Q-Line Biotech Ltd. 52 week high is 659.75 as of September 03, 2026.
What is the 52-week low for Q-Line Biotech Ltd.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Q-Line Biotech Ltd. 52 week low is 431.00 as of September 03, 2026.
What is Q-Line Biotech Ltd. stock price today?
Q-Line Biotech Ltd. stock price today is 641.00.
What was Q-Line Biotech Ltd. stock price yesterday?
Q-Line Biotech Ltd. stock price yesterday was 620.00.
What is the 50-day moving average of Q-Line Biotech Ltd.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Q-Line Biotech Ltd. 50-day moving average is 540.92.